iCIEF Total Solution
CEInfinite Auto Prep iCIEF
Thermo Fisher Scientific announces agreement with Advanced Electrophoresis Solutions Ltd to accelerate therapeutic development through cutting-edge protein analysis
AES will be attending WCBP 2022 January 25 -27! Come and check our tech video “Comprehensive and critical support for CMC strategy and CIEF method lifecycle” in the technical seminar.
About the Company
Advanced Electrophoresis Solutions Ltd. (AES) was founded in 2010. The Company is dedicated in providing cutting-edge instrumentations, ampholytes, and supplies in the iCIEF field. The Company now has become a unique total solution provider for protein iCIEF separation and characterization in the industry. The Company has been working with leading biopharmaceutical companies and research institutes to address their diversely urgent needs and save millions of dollars to meet their budget goal by avoiding potential product disruption, establishing QC methods, and helping regulatory filing.
Accelerate your biologics development,
protein characterization and save your budget.
Tiemin Huang, Ph.D.
President and CEO
Victor Li, M.Sc.
Tong Chen, Ph.D.
Gerard Rozing, Ph.D.
Dr. Rozing is a pioneer in high-performance liquid chromatography (HPLC) technology and has worked in the industry for over 30 years. He has been widely recognized by the separation science community as an outstanding researcher for his ability to bridge fundamental science with technical solutions in an industrial environment. Dr. Rozing has authored 57 well-cited publications, mainly in the separation sciences, and holds six U.S. patents.
As a Scientific Advisor of AES, Dr. Xing-Zheng Wu has been involved in capillary electrophoresis (CE) research since 1992. He is the first author of the paper (Electrophoresis, 16, 1474-1478 (1995)), which described the first iCIEF cartridge with membrane technology that allows continuous sample injection and analysis. He published over 80 original works in the fields of in-capillary pre-concentration for CE separation and detection of low concentration samples. In addition to CE, his research interests include optical beam deflection method, fluorescence, chemiluminescence, and nano-particles. Dr. Wu is a Professor of Fukuoka Institute of Technology in Japan. He holds a Ph.D. in Analytical Chemistry from the University of Tokyo.
Xing-Zeng Wu, Ph.D.
are global leading pharmaceutical
companies and universities, including
Alexion, Eli Lilly,
Biogen, Novartis, etc
University of Waterloo
University of Salzburg
VU University Amsterdam
Stanford University, etc